Harsch Mutya

CIK 00017278093 companiesREHOVOT, L3

SEC Profile

Transactions

Companies

Filings

CIK

0001727809

Recent Transactions

50 trades

Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2024-09-30$1.88/sh−105→ 149,026 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2024-07-01$1.92/sh−143→ 149,131 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2024-04-01$3.08/sh−161→ 149,274 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2024-01-02$2.28/sh−161→ 149,435 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option (right to buy)
2024-01-01+62,500→ 62,500 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2024-01-01+62,500→ 149,596 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Option (right to buy)
2023-12-13+62,500→ 62,500 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2023-12-13+62,500→ 87,096 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2023-10-02$3.83/sh−1,154→ 24,596 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2023-06-30$4.10/sh−157→ 25,750 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−40,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−30,000→ 0 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2023-05-31$3.46/sh+3,664→ 25,907 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2023-03-31$3.08/sh−478→ 22,243 total
Purchase
VYNE Therapeutics Inc.$VYNE
Common Stock
2023-03-20$2.50/sh+10,000→ 22,721 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2022-12-31$0.15/sh−1,813→ 229,144 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2022-09-30$0.22/sh−1,813→ 230,957 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2022-06-30$0.39/sh−1,813→ 232,770 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-03+30,000→ 30,000 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2022-03-31$0.65/sh−3,630→ 234,583 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2022-03-17+75,000→ 238,213 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2022-03-17+75,000→ 75,000 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-12-31$1.02/sh−1,484→ 163,213 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2021-10-11+40,000→ 40,000 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-09-30$1.39/sh−1,484→ 164,697 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2021-09-02+60,860→ 60,860 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-09-02+60,859→ 166,181 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-06-30$3.51/sh−3,551→ 105,322 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-03-31$6.84/sh−1,765→ 108,873 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2021-02-22+68,162→ 68,162 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2021-02-22+29,213→ 110,638 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-12-31$1.58/sh−1,822→ 325,703 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-11-30$1.45/sh+10,460→ 327,525 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-09-30$1.66/sh−1,822→ 317,065 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-06-30$1.73/sh−1,822→ 318,887 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-05-06+150,000→ 320,712 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-05-06+150,000→ 150,000 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-04-06$1.40/sh−4,474→ 170,712 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-04-03+26,381→ 82,884 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-04-03+92,302→ 175,186 total
Tax Payment
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-31$2.68/sh−1,688→ 56,503 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−96,365→ 0 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-03-09+41,643→ 41,643 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-03-09+57,086→ 57,086 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-09+7,548→ 7,548 total
Award
VYNE Therapeutics Inc.$VYNE
Common Stock
2020-03-09+50,643→ 58,191 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2020-03-09−12,742→ 85,490 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Ordinary Shares
2020-03-09−85,490→ 0 total
Disposition to Issuer
Foamix Pharmaceuticals Ltd.
Options
2020-03-09−50,000→ 0 total
Award
VYNE Therapeutics Inc.$VYNE
Stock Options
2020-03-09+29,620→ 29,620 total

Companies

Recent Filings

Address

C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLZMAN STREET, WEIZMANN SCIENCE PARK

REHOVOT, L3, 7670402

View on SEC.gov